Fengsheng Chen
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- Cancer-related molecular mechanisms research
Papers in
-
- Mechanisms of cancer metastasis 4
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
-
- Ferroptosis and cancer prognosis 3
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Rongcheng Luo (12 shared papers)Aimin Li (10 shared papers)Wan Zhang (2 shared papers)Qian Geng (2 shared papers)Hua Xiao (4 shared papers)Chengliang Zhang (3 shared papers)Junyi Zhang (2 shared papers)Shenglan Gao (4 shared papers)
- Journals
- International Immunopharmacology (2 papers)Cancer Letters (2 papers)Oncogene (1 paper)Phytomedicine (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Fengsheng Chen
43 papers receiving 505 citations
Peers
Comparison fields: 5 of 71
- Geriatrics and Gerontology 36
- Cancer Research 80
- Pharmacology 36
- Oncology 93
- Molecular Biology 242
Countries citing papers authored by Fengsheng Chen
This map shows the geographic impact of Fengsheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengsheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengsheng Chen more than expected).
Fields of papers citing papers by Fengsheng Chen
This network shows the impact of papers produced by Fengsheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengsheng Chen. The network helps show where Fengsheng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengsheng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 52 | |
| 2 | High expression of Sirt7 served as a predictor of adverse outcome in breast cancer. | 2015 | 46 |
| 3 | 2015 | 44 | |
| 4 | 2017 | 42 | |
| 5 | 2010 | 33 | |
| 6 | 2012 | 30 | |
| 7 | [GC-MS analysis of essential oil from the leaves of Psidium guajava]. | 1999 | 28 |
| 8 | 2015 | 23 | |
| 9 | 2021 | 21 | |
| 10 | 2018 | 21 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 2009 | 15 | |
| 14 | 2015 | 13 | |
| 15 | 2024 | 10 | |
| 16 | 2014 | 10 | |
| 17 | 2020 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2024 | 8 | |
| 20 | [Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro]. | 2008 | 8 |
About Fengsheng Chen
Fengsheng Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Cancer Research, having authored 45 papers that have together received 514 indexed citations. Recurring topics across this work include Mechanisms of cancer metastasis (4 papers), Ferroptosis and cancer prognosis (3 papers), Lung Cancer Treatments and Mutations (3 papers), RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers), Epigenetics and DNA Methylation (2 papers), Peptidase Inhibition and Analysis (2 papers) and Power Systems and Technologies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (36 citations), Cancer Research (80 citations), Pharmacology (36 citations), Oncology (93 citations) and Molecular Biology (242 citations). Fengsheng Chen has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Rongcheng Luo, Aimin Li, Wan Zhang, Qian Geng, Hua Xiao, Chengliang Zhang, Junyi Zhang, Shenglan Gao, Rong Li and Feiye Liu. Their work appears in journals such as International Immunopharmacology, Cancer Letters, Oncogene, Phytomedicine and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.